Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents.
Schafer, A I
Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents. [electronic resource] - Texas Heart Institute journal 1997 - 90-6 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
0730-2347
Aspirin--therapeutic use
Dipyridamole--therapeutic use
Hemorrhage--chemically induced
Humans
Platelet Activation
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Thrombosis--blood
Ticlopidine--therapeutic use
Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents. [electronic resource] - Texas Heart Institute journal 1997 - 90-6 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
0730-2347
Aspirin--therapeutic use
Dipyridamole--therapeutic use
Hemorrhage--chemically induced
Humans
Platelet Activation
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Thrombosis--blood
Ticlopidine--therapeutic use